Pharma Journalist -

Sarepta Therapeutics, a leader in precision genetic medicine for rare diseases, announced it has voluntarily and temporarily halted all shipments of ELEVIDYS (delandistrogene…
Read More...

Johnson & Johnson has officially submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration seeking approval for icotrokinra, an investigational first-in-class…
Read More...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected…
Read More...

Rocket Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to RP-A601, the company’s…
Read More...

Aldeyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review its resubmitted New Drug Application (NDA) for reproxalap, a first-in-class…
Read More...

Astellas Pharma Inc. announced the signing of a memorandum of understanding (MoU) with the Korea Institute of Startup and Entrepreneurship Development (KISED), a government-backed…
Read More...

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ENHERTU (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab for the…
Read More...

AlzeCure Pharma AB (publ), a Swedish pharmaceutical company focused on treatments for nervous system disorders including Alzheimer’s and pain, announced that the U.S. Food and Drug…
Read More...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to SAR446597, a one-time intravitreal gene therapy developed by Sanofi for the treatment of geographic…
Read More...

Endeavor BioMedicines, a clinical-stage biotech company focused on life-threatening diseases, announced that its investigational therapy taladegib (ENV-101) has been granted Orphan Drug…
Read More...